Prepare for the ELNEC Module 6 Test with detailed flashcards and multiple-choice questions, each with hints and explanations. Ensure your success with comprehensive study aids!

Multiple Choice

What is the ethical equivalence between withholding and withdrawing life-sustaining treatment?

Both withholding and withdrawing life-sustaining treatment are ethically equivalent when the care would be non-beneficial or not aligned with what the patient values and desires. The important factors are patient autonomy, informed consent or valid surrogate decision-making, and the goal of providing care proportional to benefits. Withholding means not starting a treatment in the first place; withdrawing means stopping a treatment that has already begun. If continuing the treatment would only prolong suffering or provide no meaningful benefit, choosing not to start it or choosing to discontinue it respects the patient’s goals and avoids futile intervention. The intent is to honor preferences and reduce burden, not to cause death, though death may occur as a result of stopping treatment. Context matters: decisions are made with the patient or a surrogate, ideally guided by advance directives and ongoing reassessment of goals and benefits.

Both withholding and withdrawing life-sustaining treatment are ethically equivalent when the care would be non-beneficial or not aligned with what the patient values and desires. The important factors are patient autonomy, informed consent or valid surrogate decision-making, and the goal of providing care proportional to benefits. Withholding means not starting a treatment in the first place; withdrawing means stopping a treatment that has already begun. If continuing the treatment would only prolong suffering or provide no meaningful benefit, choosing not to start it or choosing to discontinue it respects the patient’s goals and avoids futile intervention. The intent is to honor preferences and reduce burden, not to cause death, though death may occur as a result of stopping treatment.

Context matters: decisions are made with the patient or a surrogate, ideally guided by advance directives and ongoing reassessment of goals and benefits.